Okyo Pharma Ltd Stock Price on November 19, 2024
| OKYO Stock | USD 1.02 0.02 1.92% |
If you're considering investing in OKYO Stock, it is important to understand the factors that can impact its price. As of today, the current price of OKYO Pharma stands at 1.02, as last reported on the 30th of November, with the highest price reaching 1.06 and the lowest price hitting 1.02 during the day. OKYO Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.022, which implies the firm had a -0.022% return per unit of standard deviation over the last 3 months. OKYO Pharma exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OKYO Pharma's Semi Deviation of 3.8, risk adjusted performance of 0.0128, and Market Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide.
As of the 30th of November 2024, Stock Based Compensation is likely to grow to about 1.2 M, though Total Stockholder Equity is likely to grow to (5.6 M). . As of the 30th of November 2024, Price Earnings To Growth Ratio is likely to grow to 26.95, though Price Earnings Ratio is likely to grow to (2.4 K). OKYO Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
OKYO |
Sharpe Ratio = -0.022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OKYO |
Estimated Market Risk
| 4.43 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average OKYO Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OKYO Pharma by adding OKYO Pharma to a well-diversified portfolio.
Price Book 14.1075 | Book Value (0.18) | Enterprise Value 33.4 M | Enterprise Value Ebitda (4.29) | Shares Float 23.9 M |
Related Headline
Quoin Pharmaceuticals Headline on 19th of November 2024
Vir Biotechnology Presents Positive Chronic Hepatitis Delta ... by gurufocus.com
Vir Biotechnology, Inc. today announced positive results from the SOLSTICE Phase 2 clinical trial evaluating tobevibart alone, or in combination w
OKYO Pharma Valuation on November 19, 2024
It is possible to determine the worth of OKYO Pharma on a given historical date. On November 19, 2024 OKYO was worth 1.06 at the beginning of the trading date compared to the closed value of 1.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of OKYO Pharma stock. Still, in general, we apply an absolute valuation method to find OKYO Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of OKYO Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against OKYO Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.05 | 1.06 | 1.01 | 1.02 | 54,919 | |
11/19/2024 | 1.06 | 1.06 | 1.02 | 1.03 | 64,966 |
| 1.06 | 1.10 | 1.02 | 1.07 | 54,931 |
| Backtest OKYO Pharma | | | OKYO Pharma History | | | OKYO Pharma Valuation | Previous | Next |
OKYO Pharma Trading Date Momentum on November 19, 2024
| On November 20 2024 OKYO Pharma Ltd was traded for 1.07 at the closing time. The top price for the day was 1.10 and the lowest listed price was 1.02 . The trading volume for the day was 54.9 K. The trading history from November 20, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 3.88% . The trading delta at closing time against the current closing price is 0.97% . |
OKYO Pharma Fundamentals Correlations and Trends
By evaluating OKYO Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among OKYO Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. OKYO financial account trend analysis is a perfect complement when working with valuation or volatility modules.About OKYO Pharma Stock history
OKYO Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for OKYO is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in OKYO Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing OKYO Pharma stock prices may prove useful in developing a viable investing in OKYO Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.3 M | 27.9 M | |
| Net Loss | -4.6 M | -4.8 M |
OKYO Pharma Stock Technical Analysis
OKYO Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
OKYO Pharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
OKYO Pharma Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
OKYO Pharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how OKYO Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OKYO Pharma shares will generate the highest return on investment. By undertsting and applying OKYO Pharma stock market strength indicators, traders can identify OKYO Pharma Ltd entry and exit signals to maximize returns
OKYO Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for OKYO Pharma's price direction in advance. Along with the technical and fundamental analysis of OKYO Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of OKYO to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0128 | |||
| Jensen Alpha | 0.0373 | |||
| Total Risk Alpha | (0.86) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (2.92) | Return On Equity (29.69) |
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.